BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 21294740)

  • 1. Mitochondrial response to controlled nutrition in health and disease.
    Schiff M; Bénit P; Coulibaly A; Loublier S; El-Khoury R; Rustin P
    Nutr Rev; 2011 Feb; 69(2):65-75. PubMed ID: 21294740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders.
    Sas K; Robotka H; Toldi J; Vécsei L
    J Neurol Sci; 2007 Jun; 257(1-2):221-39. PubMed ID: 17462670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of mitochondrial disease.
    Muravchick S
    Adv Drug Deliv Rev; 2008; 60(13-14):1553-60. PubMed ID: 18647627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age related mitochondrial degenerative disorders in humans.
    Reeve AK; Krishnan KJ; Turnbull DM
    Biotechnol J; 2008 Jun; 3(6):750-6. PubMed ID: 18512864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PGC-1alpha activation as a therapeutic approach in mitochondrial disease.
    Wenz T
    IUBMB Life; 2009 Nov; 61(11):1051-62. PubMed ID: 19859975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial respiratory chain dysfunction: implications in neurodegeneration.
    Morán M; Moreno-Lastres D; Marín-Buera L; Arenas J; Martín MA; Ugalde C
    Free Radic Biol Med; 2012 Aug; 53(3):595-609. PubMed ID: 22595027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of mitochondrial OXPHOS dysfunction in the development of neurologic diseases.
    Breuer ME; Koopman WJ; Koene S; Nooteboom M; Rodenburg RJ; Willems PH; Smeitink JA
    Neurobiol Dis; 2013 Mar; 51():27-34. PubMed ID: 22426394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Review: quantifying mitochondrial dysfunction in complex diseases of aging.
    Horan MP; Pichaud N; Ballard JW
    J Gerontol A Biol Sci Med Sci; 2012 Oct; 67(10):1022-35. PubMed ID: 22459622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondrial medicine: entering the era of treatment.
    Koene S; Smeitink J
    J Intern Med; 2009 Feb; 265(2):193-209. PubMed ID: 19192036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unmasking the causes of multifactorial disorders: OXPHOS differences between mitochondrial haplogroups.
    Gómez-Durán A; Pacheu-Grau D; López-Gallardo E; Díez-Sánchez C; Montoya J; López-Pérez MJ; Ruiz-Pesini E
    Hum Mol Genet; 2010 Sep; 19(17):3343-53. PubMed ID: 20566709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomics analysis provides insight into caloric restriction mediated oxidation and expression of brain proteins associated with age-related impaired cellular processes: Mitochondrial dysfunction, glutamate dysregulation and impaired protein synthesis.
    Poon HF; Shepherd HM; Reed TT; Calabrese V; Stella AM; Pennisi G; Cai J; Pierce WM; Klein JB; Butterfield DA
    Neurobiol Aging; 2006 Jul; 27(7):1020-34. PubMed ID: 15996793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial dysfunction in a neural cell model of spinal muscular atrophy.
    Acsadi G; Lee I; Li X; Khaidakov M; Pecinova A; Parker GC; Hüttemann M
    J Neurosci Res; 2009 Sep; 87(12):2748-56. PubMed ID: 19437551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases.
    Trushina E; McMurray CT
    Neuroscience; 2007 Apr; 145(4):1233-48. PubMed ID: 17303344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amino acids and mitochondrial biogenesis.
    Nisoli E; Cozzi V; Carruba MO
    Am J Cardiol; 2008 Jun; 101(11A):22E-25E. PubMed ID: 18514622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evidence basis for coenzyme Q therapy in oxidative phosphorylation disease.
    Haas RH
    Mitochondrion; 2007 Jun; 7 Suppl():S136-45. PubMed ID: 17485245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mitochondrial genome in human adaptive radiation and disease: on the road to therapeutics and performance enhancement.
    Wallace DC
    Gene; 2005 Jul; 354():169-80. PubMed ID: 16024186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophoresis techniques to investigate defects in oxidative phosphorylation.
    Calvaruso MA; Smeitink J; Nijtmans L
    Methods; 2008 Dec; 46(4):281-7. PubMed ID: 18948205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of mitochondrial dysfunction in Alzheimer's disease.
    Castellani R; Hirai K; Aliev G; Drew KL; Nunomura A; Takeda A; Cash AD; Obrenovich ME; Perry G; Smith MA
    J Neurosci Res; 2002 Nov; 70(3):357-60. PubMed ID: 12391597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodegeneration from mitochondrial insufficiency: nutrients, stem cells, growth factors, and prospects for brain rebuilding using integrative management.
    Kidd PM
    Altern Med Rev; 2005 Dec; 10(4):268-93. PubMed ID: 16366737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.